Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: J Arthroplasty. 2022 Mar 9;37(7):1364–1368. doi: 10.1016/j.arth.2022.03.010

Table 2:

Relationship Between LTT Status and Mean Total CD4+ or CD8+ Cells/HPF

Mean Median p-value
Total CD4+ Cells/HPF
  LTT− 55.7 (88.1) 22.0 (13.0, 85.5) 0.67
  LTT+ 22.8 (18.0) 20.0 (12.3, 29.8)
Total CD8+ Cells/HPF
  LTT− 72.2 (51.9) 88.0 (13.0, 104.8) 0.09
  LTT+ 33.0 (26.9) 31.5 (11.0, 58.0)
Sub-synovial CD4+ Cells/HPF
  LTT− 34.0 (39.9) 22.0 (7.8, 54.3) 0.30
  LTT+ 13.5 (9.5) 11.5 (6.0, 18.8)
Sub-synovial CD8+ Cells/HPF
  LTT− 59.2 (38.7) 77.0 (12.0, 90.3) 0.04
  LTT+ 22.0 (22.0) 9.5 (4.0, 40.5)
Perivascular CD4+ Cells/HPF
  LTT− 21.7 (49.2) 0.5 (0.0, 35.8) 0.37
  LTT+ 9.3 (16.9) 3.0 (2.0, 7.5)
Perivascular CD4+ Cells/HPF
  LTT− 13.0 (27.9) 1.5 (0.7, 20.5) 0.56
  LTT+ 11.0 (21.5) 3.0 (1.0, 11.0)

p-value obtained using a two-tailed Mann-Whitney test. Means are displayed with standard deviation in parentheses. Medians are shown with the first and third quartiles in parentheses. LTT+ cohort N=12 and LTT− cohort N=6.